Working… Menu

EP0057 in Combination With Olaparib in Advanced Ovarian Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04669002
Recruitment Status : Recruiting
First Posted : December 16, 2020
Last Update Posted : July 6, 2021
Information provided by (Responsible Party):
Ellipses Pharma

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 2022
Estimated Study Completion Date : January 2025